Facebook
Twitter
LinkedIn
Forward
CMHC Masterclass On Demand: Women’s Cardiometabolic Health and Wellness
The visionaries at Cardiometabolic Health Congress (CMHC) – inspired by top experts in women’s health – have designed a masterclass to address the challenges in optimizing cardiometabolic health in women across the lifespan. The Women’s Cardiometabolic Health and Wellness Masterclass, led by co-chairs Pam R. Taub, MD and Erin D. Michos, MD, MHS, will explore the significant differences in risk factors, symptom presentation, preventive strategies, and treatment for cardiometabolic diseases in women, as well as important implications for patient care. This interactive educational experience will feature engaging conversations, evidence-based presentations, and clinical insights from renowned experts.
Target Audience
The educational design of this activity addresses the needs of US-based based cardiologists, endocrinologists, primary care clinicians, obstetricians, pharmacists, physicians, nurse practitioners, physician assistants, and other allied health professionals involved in the management and treatment of cardiometabolic patients.
Learning Objectives
After completing this activity, the participant should be better able to:
- Recognize the symptoms and clinical presentation of acute and chronic cardiovascular diseases in women, including heart failure, valvular disease, and acute coronary syndromes.
- List unique CVD risk factors in women across the age spectrum
- Describe the risk of cardiometabolic disease in women due to PCOS and adverse pregnancy outcomes.
- Outline the cardiometabolic safety of postmenopausal hormone therapy and contraception.
- Select individualized approaches for the screening and co-management of cardiometabolic risk and women’s health, including PCOS, postmenopausal symptoms, contraception, osteoporosis, infertility, and long-term pregnancy adverse outcomes.
Co-Chairs
Pam R. Taub, MD, FACC
Founder and Director of Step Family Cardiac Rehabilitation and
Wellness Center
Professor of Medicine
UC San Diego Health System
Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC
Associate Director of Preventive Cardiology
Associate Professor of Medicine and Epidemiology
Division of Cardiology
Johns Hopkins School of Medicine
Co-Editor in Chief
The American Journal of Preventive Cardiology
Baltimore, MD
Faculty
Sadiya S. Khan, MD, MSc, FACC, FAHA
Assistant Professor of Medicine and Preventive Medicine Associate
Program Director, Cardiovascular Disease Fellowship
Director of Research, Section of Heart Failure
Northwestern University Feinberg School of Medicine
Chicago, IL
C. Noel Bairey Merz, MD, FACC, FAHA, FESC
Irwin and Sheila Allen Trust Chair in Women’s Health Research
Director, Barbra Streisand Women’s Heart Center
Director, Linda Joy Pollin Women’s Heart Health
Program Director, Preventive Cardiac Center
Director, Erika J. Glazer Women’s Heart Research Initiative Smidt Heart Institute
Professor of Medicine, Cedars-Sinai Medical Center
Kimberly A. Skelding, MD, FACC, FAHA, FSCAI
Confluence Health, Washington
Associate Professor
University of Washington
Sunny Smith, MD
Former Clinical Professor of Family Medicine and Public Health
University of CA San Diego School of Medicine
Current Founder & CEO EWP
Shaista Malik, MD, PhD, MPH, FACC
Associate Vice Chancellor, Integrative Health
Susan and Henry Samueli College of Health Sciences
Professor, Department of Medicine, Division of Cardiology
UCI Medical Director, Preventive Cardiology and Cardiac Rehab
Rachel Perry, MD, MPH
Associate Professor of Obstetrics and Gynecology
University of California, Irvine
Orange, CA
Andrea Dunaif, MD
Lillian & Henry M. Stratton Professor of Molecular Medicine System
Chief, Hilda & J. Lester Gabrilove Division of Endocrinology, Diabetes & Bone Disease
Icahn School of Medicine – Mount Sinai Health System
Ulrika Birgersdotter-Green, MD
Professor of Medicine Division of Cardiology
UC San Diego Health
Lori B. Daniels, MD, MAS, FACC, FAHA
Professor of Medicine
Director, Cardiovascular Intensive Care Unit
Sulpizio Cardiovascular Center
UC San Diego
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS
Obesity Medicine & Nutrition, MGH Weight Center
American Board of Obesity Medicine Diplomate
Christie M. Ballantyne, MD
Baylor College of Medicine
Houston, TX
Mohamed A. Eid, MD, MPH, MHA
Vice President
Clinical Development & Medical Affairs
Cardiometabolism & Respiratory Medicine
Boehringer Ingelheim Pharmaceuticals Inc.
Ridgefield, CT
Roxana Mehran, MD, FACC
Endowed Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes
Professor of Medicine (Cardiology) and Population Health Science and Policy
Icahn School of Medicine at Mount Sinai
JoAnne M. Foody, MD
Chief Medical Officer, Esperion
Kelly Lewis, PharmD
Executive Medical Director
Head of Atherosclerosis, Clinical Development and Medical Affairs, Novartis.
Ramona Master, MD
Physician, Life Coach
UC San Diego Health
Master Peace & Strength Coaching
San Diego, CA
ESTIMATED TIME TO COMPLETE ACTIVITY
6 hours
JOINT PROVIDERSHIP STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING EDUCATION
PACE designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CONTINUING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 6 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 6 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008073-9999-23-013-H01-P Type of activity: Knowledge
DISCLOSURES
Information on planner and faculty disclosures can be found 
here
DISCLOSURE OF CONFLICT OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.
If you attended the 2022 Women's Health Masterclass, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.
During the period January 12, 2023 through January 12, 2024, participants must read the learning objectives and faculty disclosures, study the educational activity, obtain a score of 75% or better on the post-test, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at CMHC_Eval@cardiometabolichealth.org.
For additional information about the accreditation of this activity, please visit https://partnersed.com
For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.
Available Credit
- 6.00 ACPE Pharmacy
- 6.00 AMA PRA Category 1 Credit™
- 6.00 ANCC
- 6.00 Participation
Registration Fee
There is a registration fee for this activity (if you were a live attendee please refer to the below note). Registration can be found here. Once registration is complete, you will receive a confirmation email with an access code and link back to this course.
If you attended the 2022 Women's Health Masterclass, please reach out to info@cardiometabolichealth.org and we will provide you with complimentary access code to this activity.
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.